What Is Inhibikase Therapeutics, Inc. (IKT) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Inhibikase Therapeutics, Inc.'s intrinsic value is estimated at $1.33. Trading at its current price of $2.06, the valuation engine raises significant caution: 7 of 9 models flag downside risk, projecting an average implied return of -35.3%. Notably, Sentiment SOTP sees the most upside at +23.4% (fair value: $2.54), while EPV is the most conservative at -82.3% ($0.36). The spread between these extremes — +105.8% — reveals how different analytical frameworks can reach starkly different conclusions.
What Do the Models Say About IKT?
9 of 13 models are currently active for IKT. Of these, 2 models suggest upside while 7 models suggest overvaluation. The Bayesian DCF estimates IKT's intrinsic value at $0.69, implying -66.4% downside from the current price. See which stocks rank higher →
How Does IKT Rank in Biological Products, (No Diagnostic Substances)?
Among 134 Biological Products, (No Diagnostic Substances) stocks, IKT ranks #110 by Quality of Company score. CirclFi's QOC score of 4.2/10 evaluates 32 fundamental signals. A score of 4.2 reflects mixed fundamentals.
See all Most Undervalued Biological Products, (No Diagnostic Substances) Stocks →
Inhibikase Therapeutics, Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.
Is IKT a Value Trap?
CirclFi's Value Trap algorithm assigns IKT a score of 24/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
9 of 13 models are active for Inhibikase Therapeutics, Inc.. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Deep Alpha Valuation Engine, Inhibikase Therapeutics, Inc. scores 4.2 out of 10 on our 32-signal quality assessment, a moderate rating that shows mixed signals across our quality framework with notable weaknesses. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.
The gap between the most bullish and bearish model spans +105.8% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every IKT valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across IKT's 9 active models, average confidence is 23%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad